Streetbeat News

Partnerships

RMTI

Rockwell Medical has entered into a three-year co-promotion services agreement with B. Braun Medical to promote Rockwell's hemodialysis concentrates products to dialysis providers in the United States, primarily on the West Coast.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 10:10 am

FXI

China has issued measures to promote opening in some free trade zones and ports on a pilot basis to meet high international standards. This will allow foreign financial institutions in these pilot free trade zones to launch the same new services as Chinese financial institutions.

Portfolio Pulse from Charles Gross

June 29, 2023 | 9:18 am

SNY

BioMed X Institute has started its first research project in collaboration with Sanofi. The project aims to develop a computational platform that can predict the efficacy of drug candidates in virtual patient populations with high accuracy. This could address the pharmaceutical industry's current 90% failure rate of new drug candidates during clinical development.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 9:03 am

TTI

XOM

Exxon Mobil has entered into an agreement with Tetra Technologies to develop over 6,100 lithium-rich acres in Arkansas. The deal is part of Exxon's strategy to expand its lithium business.

Portfolio Pulse from Charles Gross

June 29, 2023 | 8:56 am

NDAQ

Nasdaq (NASDAQ:NDAQ) and Depósito Central de Valores (DCV) have extended their technology partnership, enabling DCV to issue and settle digitized securities. This move positions DCV as a pioneer in asset tokenization, providing its clients with a unified platform across all asset classes.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 8:20 am

EVO

Evotec SE announced that it will receive a €2m milestone payment from Bayer AG, triggered by the first patient dosed in the Phase I study of a kidney disease programme. The drug candidate, a monoclonal antibody targeting the protein Semaphorin-3A, is being developed as a potential treatment for Alport syndrome, a rare genetic kidney disease.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 7:19 am

MYNZ

Mainz Biomed NV (NASDAQ:MYNZ), a molecular genetics diagnostic company, has secured a $50 million Pre-Paid Advance Agreement (PPA) with Yorkville Advisors Global, LP, a global investment management firm. In addition, the company and Yorkville have entered into a $5.5 million Promissory Note, with approximately $5.0 million funded at closing.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 7:18 am

AMZN

CRM

GOOG

IBM

META

TWTR

Twitter's CEO Linda Yaccarino is planning to reshape the social media platform by introducing innovative strategies to win back advertisers and confront Meta Platforms Inc.'s new decentralized platform. Twitter plans to launch full-screen, sound-on video ads and is testing a new ad format. Yaccarino also plans to attract celebrities, political figures, and content creators to the platform to attract more advertising. She is also expected to invest in rebuilding Twitter’s advertising, sales and partnership team and is in discussions for a potential broader partnership with Google. Yaccarino also aims to renegotiate contracts with Amazon.com, Inc., Salesforce and IBM.

Portfolio Pulse from Ananya Gairola

June 29, 2023 | 6:29 am

BAC

JOBY

OSTK

TSLA

U.S. stocks traded mixed with Dow Jones dropping around 70 points and NASDAQ rising 0.27%. Micron Technology's stock rose 0.42% due to better-than-expected Q3 results. Joby Aviation's stock soared 40.22% after receiving a permit for flight testing of its first production prototype. Tesla's stock rose 2.41% after Volvo joined Tesla’s charging network. Bank of America's stock fell 0.60% despite passing the 2023 stress test conducted by the Federal Reserve. Overstock.com's stock rose 6.11% for reasons yet to be identified.

Portfolio Pulse from Benzinga Newsbot

June 29, 2023 | 12:49 am

PARA

WBD

Portfolio Pulse from Chris Katje

June 28, 2023 | 10:11 pm